ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026
Advances in Treatment of Psychiatric Disorders in Patients with HIV.
Review in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in neuropsychiatry: From objective diagnostics to mechanism-based therapeutics.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psychiatric disorders have been shown to be risk factors for infection with HIV but have also been shown to be consequences of HIV infection, as well as barriers to effective care. Psychiatric disorders are associated with poor treatment outcomes, increased morbidity and mortality. Integrated care in clinics where mental health services are combined with psychiatric services has been shown to be effective in overcoming these issues. Major depression is a common psychiatric disorder in HIV patients at a 3-5 fold increased prevalence over background rates. Major depression increases the risk for infection but has also been shown to be a consequence of viral brain injury. Major depression is a barrier to successful treatment of HIV. Bipolar disorder has similar associations, but the data is weaker. Personality disorders are a risk factor for HIV infection, cause frustration for clinicians and are associated with poor treatment outcomes. This issue can be mitigated by integrated care of patients with this co-morbidity. Substance use and addiction are fundamental factors in HIV transmission. They are often encountered in clinics that treat HIV, but are often a barrier to care because of the lack of expertise in treating these conditions. Numerous psychological stressors are associated with HIV infection. Stigma, Post Traumatic Stress Disorder (PTSD) and disenfranchisement from medical care are surmountable barriers when psychiatric care is integrated with medical care. HIV populations are often underserved and impoverished and cutbacks in coverage for medical care will sabotage the efforts to eliminate HIV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.